Literature DB >> 17315179

Cardiovascular mortality among Swedish pulp and paper mill workers.

Bodil Persson1, Anders Magnusson, Håkan Westberg, Eva Andersson, Kjell Torén, Gun Wingren, Olav Axelson.   

Abstract

BACKGROUND: Malignant diseases but also cardiovascular and respiratory disorders and diabetes mellitus have been associated with work in pulp and paper production. The present cohort focuses on cardiovascular mortality in relation to various exposures in this industry.
METHODS: The cohort, followed-up for mortality, includes 7,107 workers, 6,350 men and 757 women, from three major old mills in the middle of Sweden.
RESULTS: Instead of a healthy-worker effect, a slightly increased risk for death in diseases of the circulatory system was found for male workers. Notably, work with sulfate digestion, steam and power generation and maintenance was associated with significantly increased risks. Cerebrovascular diseases showed non-significantly increased risks for maintenance and paper and paperboard production and manufacture.
CONCLUSIONS: The differences in risk among various parts of the production are striking although it is hard to pinpoint any specific exposures. Dust and small particles along with sulfur compounds might be suspected. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17315179     DOI: 10.1002/ajim.20449

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  2 in total

1.  Inflammatory markers and exposure to airborne particles among workers in a Swedish pulp and paper mill.

Authors:  Håkan Westberg; Karine Elihn; Eva Andersson; Bodil Persson; Lennart Andersson; Ing-Liss Bryngelsson; Cathe Karlsson; Bengt Sjögren
Journal:  Int Arch Occup Environ Health       Date:  2016-02-13       Impact factor: 3.015

2.  Elevated monocyte phosphorylated p38 in nearby employees after a chemical explosion.

Authors:  André Sulen; Stein H L Lygre; Sigrun M Hjelle; Bjørg E Hollund; Bjørn T Gjertsen
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.